Spotlight on: ASCO 2026
Updates from oncology’s biggest weekend
May 29 – June 2, 2026 | McCormick Place, Chicago, IL & Online
2026 ASCO Annual Meeting
Once again, pharmaphorum will be onsite at ASCO 2026, keeping you up to date on all the practice-changing new data as well as the trends and topics of discussion in Chicago. This “Spotlight On” page is your hub for ongoing coverage, including expert interviews, news bulletins, and more.
This year is shaping up to be a big one with potentially practice-changing data in lung cancer, breast cancer, prostate cancer, and more – plus some early data in cutting-edge spaces like radiotherapeutics and in vivo cell therapy.
The nation’s top oncologists will also compare notes on AI and digital tools, and we may see some interesting conversations around GLP-1s and early-onset cancer as well.
Keep this page bookmarked for news from the show as it happens, and even more analysis after the fact.
Reported by Jonah Comstock
Jonah Comstock is a veteran health tech and digital health reporter who in recent years has turned his talents toward the pharma sector. In addition to covering healthcare for more than a decade through his articles, videos, and podcasts, he is also an oft-seen face at healthcare events, both on and off the stage. He has moderated sessions at HIMSS, BIO, and Health 2.0, among others. He's a graduate of the Columbia University School of journalism and in 2021 he was part of the inaugural class of the CUNY Executive Program in News Innovation and Leadership.
Highlights from the past ASCO conferences
ASCO25 reflections: Oncology’s evolution over the last decade and a new era on the horizon
Oncology has long set the pace for biomedical innovation, but the nature of that innovation is changing. The field is shifting from a decade built on sweeping breakthroughs to one defined by nuance, complexity, and increasingly demanding strategic decisions.
ASCO25 offered a glimpse of where the field is heading. For newer entrants, the challenge lies in carving out a place within an increasingly competitive landscape, shaped by biomarker-defined subgroups and combination strategies.
Heard on the pipeline: ASCO 2024
Every year, the American Society of Clinical Oncology (ASCO) annual meeting brings together a worldwide community of innovators dedicated to advancing the frontiers of cancer research.
Amidst a wealth of knowledge and experience, pharmaphorum editor-in-chief, Jonah Comstock, was presented with a profound opportunity on the ASCO floor: the passing of the torch to the next generation of oncology experts.
About ASCO
The ASCO Annual Meeting (American Society of Clinical Oncology) is the world’s premier oncology event, gathering tens of thousands of cancer clinicians, researchers, and healthcare innovators globally.
As the ultimate stage for groundbreaking clinical trial results, ASCO is where next-generation treatments—from targeted therapies to AI-driven diagnostics—are unveiled. It is the defining forum that shapes global clinical guidelines and drives the future of cancer care.